Tehran University of Medical Sciences

Science Communicator Platform

Stay connected! Follow us on X network (Twitter):
Share this content! On (X network) By
Current Challenges and New Opportunities of Hybrid Nanoparticles for Diagnosis and Treatment of Cancer Publisher



Tarighatnia A1, 2 ; Mahmoudi G3 ; Kiani M4 ; Nader ND5
Authors
Show Affiliations
Authors Affiliations
  1. 1. Department of Medical Physics, School of Medicine, Ardabil University of Medical Sciences, Ardabil, Iran
  2. 2. Research Center for Pharmaceutical Nanotechnology, Tabriz University of Medical Sciences, Tabriz, Iran
  3. 3. Medical Imaging Technology Department, School of Allied Medical Sciences, Shahroud University of Medical Sciences, Shahroud, Iran
  4. 4. Research Center for Molecular and Cellular Imaging, Tehran University of Medical Sciences, Tehran, Iran
  5. 5. Jacobs School of Medicine and Biomedical Sciences, University at Buffalo, Buffalo, NY, United States

Source: Frontiers in Biomedical Technologies Published:2024


Abstract

Hybrid Nanoparticles (NPs) have emerged as promising tools in cancer diagnosis and treatment, offering the potential for early detection and precise eradication of malignant cells by integrating diverse materials. However, navigating this domain's intricacies, limitations, and hurdles underscores the importance of thoughtful decision-making. This editorial provides a comprehensive exploration of the merits and challenges of nanotechnology in the context of cancer diagnosis, therapy, and theranostics. It sheds light on the current applications and delves into the promising prospects in this field. This editorial aims to foster a deeper understanding of the intricacies of designing efficient protocols for hybrid NP production, contributing to advancing cancer management strategies. © 2024 Tehran University of Medical Sciences.